Education
About Us
Working with TipRanks
Follow Us
Mankind Pharma Ltd. (IN:MANKIND)
:MANKIND
RESEARCH TOOLSreports
Total Valuation
Mankind Pharma Ltd. has a market cap or net worth of ₹970.10B. The enterprise value is ₹971.93B.
Market Cap₹970.10B
Enterprise Value₹971.93B
Share Statistics
Mankind Pharma Ltd. has 412.58M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding412.58M
Owened by Insiders
Owened by Instutions
Financial Efficiency
Mankind Pharma Ltd.’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee―
Profits Per Employee―
Employee Count
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Mankind Pharma Ltd. is ―. Mankind Pharma Ltd.’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Mankind Pharma Ltd. had revenue of ₹106.50B and earned ₹19.63B in profits. Earnings per share was ₹48.99.
Revenue₹106.50B
Gross Profit₹67.06B
Operating Income₹23.76B
Pretax Income₹24.39B
Net Income₹19.63B
EBITDA28.85B
Earnings Per Share (EPS)48.99
Cash Flow
In the last 12 months, operating cash flow was ₹4.12B and capital expenditures ₹0.00, giving a free cash flow of ₹4.12B billion.
Operating Cash Flow₹4.12B
Free Cash Flow₹4.12B
Free Cash Flow per Share₹10.00
Dividends & Yields
Mankind Pharma Ltd. pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.45
52-Week Price Change3.82%
50-Day Moving Average2.37K
200-Day Moving Average2.45K
Relative Strength Index (RSI)59.05
Average Volume (3m)13.61K
Important Dates
Mankind Pharma Ltd. upcoming earnings date is Jun 3, 2025, Before Open.
Last Earnings DateJan 23, 2025
Next Earnings DateJun 3, 2025
Ex-Dividend Date―
Financial Position
Mankind Pharma Ltd. as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Mankind Pharma Ltd. has paid ₹4.52B in taxes.
Income Tax₹4.52B
Effective Tax Rate―
Enterprise Valuation
Mankind Pharma Ltd. EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Mankind Pharma Ltd. has ₹33.86B in cash and marketable securities with ₹0.00 in debt, giving a net cash position of -₹33.86B billion.
Cash & Marketable Securities₹33.86B
Total Debt₹0.00
Net Cash-₹33.86B
Net Cash Per Share-₹82.08
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Mankind Pharma Ltd. is ₹2863.75, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target₹2863.75
Price Target Upside23.68%
Analyst ConsensusModerate Buy
Analyst Count4
Revenue Growth Forecast
EPS Growth Forecast